メーカー 略称 |
製品コード |
TaKaRa Code |
製品名 |
容量 |
価格(税別) |
特記事項 |
説明書 データシート ベクター情報 |
参考 資料 |
PCI |
C-64130 |
D15240 |
RANTES (CCL5), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-63200 |
D15166 |
soluble Receptor Activator of NF-Kappa-B Ligand (E. coli-derived), (sRANKL), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63201 |
D15168 |
soluble Receptor Activator of NF-Kappa-B Receptor (TNFRSF11A), (sRANK Receptor), rHuman
|
100 μg |
¥40,000
|
|
 |
|
PCI |
C-66674 |
D15362 |
Relaxin 2, rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-66676 |
D15363 |
Relaxin 3, rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-66670 |
D15361 |
Resistin, rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-66665 |
D15360 |
Resistin-like Molecule beta, (RELM beta), rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-66685 |
D15366 |
Retinol Binding Protein 4, (RBP-4), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-66679 |
D15364 |
Sonic Hedgehog (E. coli-derived), (Shh), rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-63120 |
D15161 |
Stem Cell Factor (E. coli-derived), (SCF), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63120A |
D15162 |
Stem Cell Factor (plant-derived), (SCF), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63125 |
D15163 |
Stem Cell Factor (Sf9 insect cell-derived), (SCF), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63130 |
D15164 |
Stem Cell Growth Factor alpha, (SCGF-alpha), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63140 |
D15165 |
Stem Cell Growth Factor beta, (SCGF-beta), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-67220 |
D15373 |
Stromal Cell Derived Factor 1-alpha (CXCL12), (SDF-1 alpha), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-67320 |
D15382 |
Stromal Cell Derived Factor 1-beta (CXCL12), (SDF-1 beta), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63620 |
D15207 |
TAFA 2, rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-65062 |
D15282 |
Thrombomodulin (CD141), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-65112 |
D15284 |
Thrombopoietin (Mp1-ligand, MGDF; E. coli-derived), (TPO), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63770 |
D15228 |
Thymic Stromal Lymphopoietin, (TSLP), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-68010 |
D15424 |
Thymus and Activation Regulated Chemokine (CCL17), (TARC), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-68020 |
D15430 |
Thymus Expressed Chemokine (CCL25), (TECK), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-68025 |
D15431 |
soluble TIE-1/Fc Chimera (Sf9 insect cell-derived), (sTIE-1/Fc Chimera), rHuman
|
20 μg |
¥33,600
|
|
 |
|
PCI |
C-68028 |
D15432 |
soluble TIE-2/Fc Chimera (Sf9 insect cell-derived), (sTIE-2/Fc Chimera), rHuman
|
20 μg |
¥35,000
|
|
 |
|
PCI |
C-68560 |
D15457 |
Tissue Inhibitor of Metalloproteinases 1, (TIMP-1), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-65065 |
D15283 |
TNF-like 1A (TNFSF15), (TL-1A), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-63602 |
D15204 |
soluble TNF Related Apoptosis Inducing Ligand Receptor 2 (DR5), (sTRAIL Receptor-2), rHuman
|
50 μg |
¥40,000
|
|
 |
|
PCI |
C-63612 |
D15206 |
TNF-Related Weak Inducer of Apoptosis Receptor, (TWEAK Receptor), rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-63610 |
D15205 |
TNF-Related Weak Inducer of Apoptosis, (TWEAK), rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-63535 |
D15200 |
Transforming Growth Factor alpha, (TGF-alpha), rHuman
|
100 μg |
¥40,000
|
|
 |
|
PCI |
C-63540 |
D15201 |
Transforming Growth Factor Beta Receptor 2, (TGF-betaR2), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63500 |
D15191 |
Transforming Growth Factor beta-1 (113 aa, E. coli-derived), (TGF-beta 1), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63497 |
D15468 |
Transforming Growth Factor beta-2 (HEK cell-derived), (TGF-beta 2), rHuman
|
10 μg |
¥38,500
|
|
 |
|
PCI |
C-63498 |
D15469 |
Transforming Growth Factor beta-2 (Hi-5 insect cell-derived), (TGF-beta 2), rHuman
|
10 μg |
¥38,500
|
|
 |
|
PCI |
C-63508 |
D15199 |
Transforming Growth Factor beta-3 (CHO cell-derived), (TGF-beta 3), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-63507 |
D15197 |
Transforming Growth Factor beta-3 (E. coli-derived), (TGF-beta 3), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-66690 |
D15367 |
Transmembrane Activator and CAML Interactor, (TACI), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-65050 |
D15279 |
Trefoil Factor 1, (TFF-1), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-65052 |
D15280 |
Trefoil Factor 2, (TFF-2), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-65053 |
D15281 |
Trefoil Factor 3, (TFF-3), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-63719 |
D15208 |
Tumor Necrosis Factor alpha (E. coli-derived), (TNF-alpha), rHuman
|
50 μg |
¥40,000
|
|
 |
|
PCI |
C-63722 |
D15212 |
Tumor Necrosis Factor alpha (E. coli-derived), (TNF-alpha), rHuman
|
10 μg |
¥14,000
|
|
 |
|
PCI |
C-63720A |
D15210 |
Tumor Necrosis Factor alpha (plant-derived), (TNF-alpha), rHuman
|
50 μg |
¥40,000
|
|
 |
|
PCI |
C-63720 |
D15209 |
Tumor Necrosis Factor alpha (yeast-derived), (TNF-alpha), rHuman
|
10 μg |
¥14,000
|
|
 |
|
PCI |
C-63721 |
D15211 |
Tumor Necrosis Factor alpha (yeast-derived), (TNF-alpha), rHuman
|
50 μg |
¥40,000
|
|
 |
|
PCI |
C-63723 |
D15213 |
Tumor Necrosis Factor alpha, Mutant/Variant (151 aa variant), (TNF-alpha M), rHuman
|
50 μg |
¥40,000
|
|
 |
|
PCI |
C-63731 |
D15216 |
Tumor Necrosis Factor beta (E. coli-derived), (TNF-beta), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-63733 |
D15218 |
Tumor Necrosis Factor beta (insect cell-derived), (TNF-beta), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-63726 |
D15215 |
Tumor Necrosis Factor Receptor Fusion Protein, (TNF-Receptor Fusion Protein), rHuman
|
50 μg |
¥40,000
|
|
 |
|
PCI |
C-63725 |
D15214 |
soluble Tumor Necrosis Factor Receptor Type I (CD120a), (sTNF-R1), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-63760 |
D15226 |
soluble Tumor Necrosis Factor Receptor Type II (CD120b), (sTNF-R2), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-63600 |
D15202 |
Tumor Necrosis Factor-Related Apoptosis Inducing Ligand, (TRAIL (Apo2L)), rHuman
|
50 μg |
¥40,000
|
|
 |
|
PCI |
C-60063 |
D15021 |
Vascular Cell Adhesion Molecule 1 (CD106), (VCAM-1), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64410 |
D15248 |
Vascular Endothelial Cell Growth Factor 121 (E. coli-derived), (VEGF-121), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64409 |
D15247 |
Vascular Endothelial Cell Growth Factor 121 (Sf9-insect cell-derived), (VEGF-121), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64424 |
D15261 |
Vascular Endothelial Cell Growth Factor 165 (CHO cell-derived), (VEGF-165), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64420 |
D15257 |
Vascular Endothelial Cell Growth Factor 165 (E. coli-derived), (VEGF-165), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64423 |
D15260 |
Vascular Endothelial Cell Growth Factor 165 (HEK cell-derived), (VEGF-165), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64420A |
D15258 |
Vascular Endothelial Cell Growth Factor 165 (plant-derived), (VEGF-165), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64421 |
D15259 |
Vascular Endothelial Cell Growth Factor 165 (yeast-derived), (VEGF-165), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64415 |
D15254 |
Vascular Endothelial Cell Growth Factor 189, (VEGF-189), rHuman
|
20 μg |
¥69,600
|
|
 |
|
PCI |
C-64411 |
D15250 |
Vascular Endothelial Cell Growth Factor B, (VEGF-B), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-64412 |
D15251 |
Vascular Endothelial Cell Growth Factor C, (VEGF-C), rHuman
|
20 μg |
¥60,000
|
|
 |
|
PCI |
C-64414 |
D15253 |
Vascular Endothelial Cell Growth Factor D, (VEGF-D), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64416 |
D15255 |
Vascular Endothelial Cell Growth Factor E, recombinant orf virus
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-64413 |
D15252 |
Vascular Endothelial Cell Growth Factor-EG, (EG-VEGF), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-64425 |
D15262 |
soluble Vascular Endothelial Growth Factor Receptor 1 (flt-1, native, Sf9 insect cell-derived), (sVEGFR-1), rHuman
|
20 μg |
¥47,000
|
|
 |
|
PCI |
C-64460 |
D15267 |
soluble Vascular Endothelial Growth Factor Receptor 1 (flt-1, native, Sf9 insect cell-derived), (sVEGFR-1), rHuman
|
5 μg |
¥19,200
|
|
 |
|
PCI |
C-64430 |
D15264 |
soluble Vascular Endothelial Growth Factor Receptor 1, Domain 1-3 (flt-1; Sf9 insect cell-derived), (sVEGFR-1), rHuman
|
5 μg |
¥40,000
|
|
 |
|
PCI |
C-64440 |
D15265 |
soluble Vascular Endothelial Growth Factor Receptor 1, Domain 1-4 (flt-1; Sf9 insect cell-derived), (sVEGFR-1), rHuman
|
5 μg |
¥40,000
|
|
 |
|
PCI |
C-64450 |
D15266 |
soluble Vascular Endothelial Growth Factor Receptor 1, Domain 1-5 (flt-1; Sf9 insect cell-derived), (sVEGFR-1), rHuman
|
5 μg |
¥19,200
|
|
 |
|
PCI |
C-64465 |
D15268 |
soluble Vascular Endothelial Growth Factor Receptor 1, Domain 1-7 (flt-1, Fc chimera; Sf9 insect cell-derived), (sVEGFR-1), rHuman
|
10 μg |
¥15,500
|
|
 |
|
PCI |
C-64472 |
D15270 |
soluble Vascular Endothelial Growth Factor Receptor 2, Domain 1-7 (sKDR, Fc chimera; Sf9 insect cell-derived), (sVEGFR-2), rHuman
|
10 μg |
¥19,200
|
|
 |
|
PCI |
C-64470 |
D15269 |
soluble Vascular Endothelial Growth Factor Receptor 2, Domain 1-7 (sKDR; Sf9 insect cell-derived), (sVEGFR-2), rHuman
|
5 μg |
¥15,500
|
|
 |
|
PCI |
C-64428 |
D15263 |
soluble Vascular Endothelial Growth Factor Receptor-3 (flt-4, native, Sf9 insect cell-derived), (sVEGFR-3), rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-68325 |
D15452 |
Vaspin, rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-68330 |
D15453 |
Visfatin, rHuman
|
25 μg |
¥40,000
|
|
 |
|
PCI |
C-69201 |
D15470 |
Vitronectin, rHuman
|
500 μg |
¥38,500
|
|
 |
|
PCI |
C-68340 |
D15454 |
WNT Inhibitory Factor 1, (WIF-1), rHuman
|
5 μg |
¥56,000
|
|
 |
|
PCI |
C-68316 |
D15449 |
WNT-1, rHuman
|
10 μg |
¥40,000
|
|
 |
|
PCI |
C-66550 |
D15344 |
4-1BB Ligand (CD137L), rHuman
|
20 μg |
¥40,000
|
|
 |
|
PCI |
C-66551 |
D15345 |
4-1BB soluble Receptor (CD137), rHuman
|
20 μg |
¥40,000
|
|
 |
|